A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma
[en] Background
In this study, we assess the effectiveness of inhaled doxycycline, a tetracycline antibiotic displaying matrix metalloproteinases (MMP) inhibitory effects to prevent allergen-induced inflammation, hyperresponsiveness and remodeling. MMPs play key roles in the complex cascade of events leading to asthmatic phenotype.
Methods
Doxycycline was administered by aerosols by the mean of a novel formulation as a complex with hydroxypropyl-gamma-cyclodextrin (HP-gamma-CD) used as an excipient. BALB/c mice (n = 16–24 in each group) were sensitized and exposed to aerosolized ovalbumin (OVA) from day 21 to 27 (short-term exposure protocol) or 5 days/odd weeks from day 22 to 96 (long-term exposure protocol).
Results
In the short-term exposure model, inhaled doxycycline decreased allergen-induced eosinophilic inflammation in bronchoalveolar lavage (BAL) and in peribronchial areas, as well as airway hyperresponsiveness. In lung tissue, exposure to doxycycline via inhaled route induced a fourfold increase in IL-10 levels, a twofold decrease in IL-5, IL-13 levels and diminished MMP-related proteolysis and the proportion of activated MMP-9 as compared to placebo.
In the long-term exposure model, inhaled doxycycline significantly decreased the extent of glandular hyperplasia, airway wall thickening, smooth muscle hyperplasia and subepithelial collagen deposition which are well recognized features of airway remodeling.
Conclusion
Doxycycline administered by aerosols decreases the allergen-induced airway inflammation and hyperresponsiveness and inhibits the development of bronchial remodeling in a mouse model of asthma by modulation of cytokines production and MMP activity.
Disciplines :
Biochemistry, biophysics & molecular biology
Author, co-author :
Guéders, Maud ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Bertholet, P.
Perin, Fabienne ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Rocks, Natacha ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Botta, Vincent ; Université de Liège - ULiège > Dép. d'électric., électron. et informat. (Inst.Montefiore) > Systèmes et modélisation
Louis, Renaud ; Centre Hospitalier Universitaire de Liège - CHU > Pneumologie-Allergologie
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Evrard, Brigitte ; Université de Liège - ULiège > Département de pharmacie > Pharmacie galénique
Cataldo, Didier ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biochimie et physiologie générales, humaines et path.
Language :
English
Title :
A novel formulation of inhaled doxycycline reduces allergen-induced inflammation, hyperresponsiveness and remodeling by matrix metalloproteinases and cytokines modulation in a mouse model of asthma
Cataldo D.D., Gueders M.M., Rocks N., Sounni N.E., Evrard B., Bartsch P., et al. Pathogenic role of matrix metalloproteases and their inhibitors in asthma and chronic obstructive pulmonary disease and therapeutic relevance of matrix metalloproteases inhibitors. Cell Mol Biol 49 (2003) 875-884
Pauwels R.A., Pedersen S., Busse W.W., Tan W.C., Chen Y.Z., Ohlsson S.V., et al. Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial. Lancet 361 (2003) 1071-1076
Chung K.F., and Barnes P.J. Cytokines in asthma. Thorax 54 (1999) 825-857
Lukacs N.W. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 1 (2001) 108-116
O'Byrne P.M., Inman M.D., and Adelroth E. Reassessing the Th2 cytokine basis of asthma. Trends Pharmacol Sci 25 (2004) 244-248
Wills-Karp M. Interleukin-13 in asthma pathogenesis. Curr Allergy Asthma Respir 4 (2004) 123-131
Cataldo D.D., Tournoy K.G., Vermaelen K., Munaut C., Foidart J.M., Louis R., et al. Matrix metalloproteinase-9 deficiency impairs cellular infiltration and bronchial hyperresponsiveness during allergen-induced airway inflammation. Am J Pathol 161 (2002) 491-498
Kumar R.K., and Foster P.S. Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 27 (2002) 267-272
Gueders M.M., Foidart J.M., Noël A., and Cataldo D.D. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 533 (2006) 133-144
Vieillard-Baron A., Frisdal E., Eddahibi S., Deprez I., Baker A.H., Newby A.C., et al. Inhibition of matrix metalloproteinases by lung TIMP-1 gene transfer or doxycycline aggravates pulmonary hypertension in rats. Circ Res 87 (2000) 418-425
Cataldo D., Gueders M., Munaut C., Rocks N., Bartsch P., Foidart J.M., et al. Matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs) mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest 84 (2004) 418-424
Cataldo D., Munaut C., Noel A., Frankenne F., Bartsch P., Foidart J.M., et al. MMP-2 and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 123 (2000) 259-267
Cataldo D.D., Bettiol J., Noel A., Bartsch P., Foidart J.M., and Louis R. Matrix metalloproteinase-9, but not tissue inhibitor of matrix metalloproteinase-1, increases in the sputum from allergic asthmatic patients after allergen challenge. Chest 122 (2002) 1553-1559
Kelly E.A., Busse W.W., and Jarjour N.N. Increased matrix metalloproteinase-9 in the airway after allergen challenge. Am J Respir Crit Care Med 162 (2000) 1157-1161
Vermaelen K.Y., Cataldo D., Tournoy K., Maes T., Dhulst A., Louis R., et al. Matrix metalloproteinase-9-mediated dendritic cell recruitment into the airways is a critical step in a mouse model of asthma. J Immunol 171 (2003) 1016-1022
Kumagai K., Ohno I., Okada S., Ohkawara Y., Suzuki K., Shinya T., et al. Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J Immunol 162 (1999) 4212-4219
Bendeck M.P., Conte M., Zhang M., Nili N., Strauss B.H., and Farwell S.M. Doxycycline modulates smooth muscle cell growth, migration, and matrix remodeling after arterial injury. Am J Pathol 160 (2002) 1089-1095
Lee C.Z., Xu B., Hashimoto T., McCulloch C.E., Yang G.Y., and Young W.L. Doxycycline suppress cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model. Stroke 35 (2004) 1715-1719
Smith G.N., Mickler E.A., Hasty K.A., and Brandt K.D. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of the enzyme. Arthritis Rheum 42 (1999) 1140-1146
Hanemaaijer R., Visser H., Koolwijk P., Sorsa T., Salo T., Golub L.M., et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res 12 (1998) 114-118
Li D.Q., Lokeshwar B.L., Solomon A., Monroy D., Ji Z., and Pflugfelder S.C. Regulation of MMP-9 production by human corneal epithelial cells. Exp Eye Res 73 (2001) 449-459
Pyo R., Lee J.K., Shipley J.M., Curci J.A., Mao D., Ziporin S.J., et al. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105 (2000) 1641-1649
Onoda T., Ono T., Dhar D.K., Yamanoi A., Fujii T., and Nagasue N. Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells. J Lab Clin Med 143 (2004) 207-216
Smith-Norowitz T.A., Bluth M.H., Drew H., Norowitz K.B., Chice S., Shah V.N., et al. Effect of minocycline and doxycycline on IgE responses. Ann Allergy Asthma Immunol 89 (2002) 172-179
Gilbertson-Beadling S., Powers E.A., Stamp-Cole M., Scott P.S., Wallace T.L., Copenland J., et al. The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism. Cancer Chemother Pharmacol 36 (1995) 418-424
Golub L.M., Sorsa T., Lee H.M., Ciancio S., Sorbi D., Ramamurthy N.S., et al. Doxycycline inhibits neutrophil (PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 22 (1995) 100-109
Lipsky P.E., van der Heijde D.M., St Clair E.W., Furst D.E., Breedveld F.C., Kalden J.R., et al. Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with Concomitant Therapy Study Group. N Engl J Med 343 (2000) 1594-1602
Berry M.A., Hardagon B., Shelley M., Parker D., Shaw D.E., Green R.H., et al. Evidence of a role of tumor necrosis factor alpha in refractory asthma. N Engl J Med 354 (2006) 697-708
Evrard B., Bertholet P., Gueders M., Flament M.P., Piel G., Delattre L., et al. Cyclodextrins as a potential carrier in drug nebulization. J Control Release 96 (2004) 403-410
Hantos Z., Daroczy B., Suki B., Nagy S., and Fredberg J.J. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72 (1992) 168-178
Gueders M.M., Balbin M., Rocks N., Foidart J.M., Gosset P., Louis R., et al. Matrix metalloproteinase-8 deficiency promotes granulocytic allergen-induced airway inflammation. J Immunol 175 (2005) 2589-2687
Lee K.S., Jin S.M., Kim S.S., and Lee Y.C. Doxycycline reduces airway inflammation and hyperresponsiveness in a murine model of toluene diisocyanate-induced asthma. J Allergy Clin Immunol 113 (2004) 902-909
Sundar K.M., Elliott C.G., and Thomsen G.E. Tetracycline aspiration. Case report and review of the literature. Respiration 68 (2001) 416-419
Zhu Z., Homer R.J., Wang Z., Chen Q., Geba G.P., Wang J., et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103 (1999) 779-788
Matsumoto K., Inoue H., Fukuyama S., Tsuda M., Ikegami T., Kibe A., et al. Decrease of interleukin-10-producing T cells in the peripheral blood of severe unstable atopic asthmatics. Int Arch Allergy Immunol 134 (2004) 295-302
Vissers J.L., van Esch B.C., Hofman G.A., Kapsenberg M.L., Weller F.R., and van Oosterhout A.J. Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J Allergy Clin Immunol 113 (2004) 1204-1210
Takanaski S., Nonaka R., Xing Z., O'Byrne P., Dolovich J., and Jordana M. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J Exp Med 180 (1994) 711-715
Dao N., and Robinson D.S. Fluticasone propionate increases CD4CD25 T regulatory cell suppression of allergen-stimulated CD4CD25 T cells by an IL-10-dependent mechanism. J Allergy Clin Immunol 114 (2004) 296-301
Stearns M.E., Kim G., Garcia F., and Wang M. Interleukin-10 induced activating transcription factor 3 transcriptional suppression of matrix metalloproteinase-2 gene expression in human prostate CPTX-1532 Cells. Mol Cancer Res 2 (2004) 403-416
Stearns M.E., Wang M., Hu Y., and Garcia F.U. Interleukin-10 activation of the interleukin-10E1 pathway and tissue inhibitor of metalloproteinase-1 expression is enhanced by proteasome inhibitors in primary prostate tumor lines. Mol Cancer Res 1 (2003) 631-642
D'Agostino P., Arcoleo F., Barbera C., Di Bella G., La Rosa M., Misiano G., et al. Tetracycline inhibits the nitric oxide synthase activity induced by endotoxin in cultured murine macrophages. Eur J Pharmacol 346 (1998) 283-290
Milano S., Arcoleo F., D'Agostino P., and Cillari E. Intraperitoneal injection of tetracyclines protects mice from lethal endotoxemia downregulating inducible nitric oxide synthase in various organs and cytokine and nitrate secretion in blood. Antimicrob Agents Chemother 41 (1997) 117-121
Gabazza E., Taguchi O., Tamaki S., Murashima S., Kobayashi H., Yasui H., et al. Role of nitric oxide in airway remodelling. Clin Sci 98 (2000) 291-294
Curci J.A., Petrinec D., Liao S., Golub L.M., and Thompson R.W. Pharmacologic suppression of experimental abdominal aortic aneurysms: a comparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg 28 (1998) 1082-1093
Camp T., Tyagi S., Aru G., Hayden M., Mehta J., and Tyagi S. Doxycycline ameliorates ischemic and border-zone remodelling and endothelial dysfunction after myocardial infarction in rats. J Heart Lung Transpl 23 (2004) 729-736
Smith V.A., and Cook S.D. Doxycycline-a role in ocular surface repair. Br J Ophtalmo 88 (2004) 619-625
Peterson J.T. Matrix metalloproteinase inhibitor development and the remodelling of drug discovery. Heart Failure Reviews 9 (2004) 63-79
Golub L.M., Lee H.M., and Ryan M.E. Tetracyclines inhibit connective tissue breakdown by multiple non-antimicrobial mechanisms. Adv Dent Res 12 (1998) 12-26
